Globespeciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-12-2024
- Paid Up Capital ₹ 1.00 M
as on 30-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.10 Cr
as on 30-12-2024
- Revenue 125.49%
(FY 2023)
- Profit -143.05%
(FY 2023)
- Ebitda -643.37%
(FY 2023)
- Net Worth -79.37%
(FY 2023)
- Total Assets 266.14%
(FY 2023)
About Globespeciality Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.10 Cr.
Puneet Bansal and Arti Bansal serve as directors at the Company.
- CIN/LLPIN
U24299PN2019PTC182493
- Company No.
182493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Globespeciality Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Bansal  | Director | 26-Feb-2019 | Current |
| Arti Bansal | Director | 26-Feb-2019 | Current |
Financial Performance of Globespeciality Chemicals.
Globespeciality Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 125.49% increase. The company also saw a substantial fall in profitability, with a 143.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Globespeciality Chemicals?
Unlock access to Globespeciality Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹31.00 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 3.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2022 | Idbi Bank Limited | ₹3.10 Cr | Open |
How Many Employees Work at Globespeciality Chemicals?
Unlock and access historical data on people associated with Globespeciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Globespeciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globespeciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.